Now Available: Final Rule for FDAAA 801 and NIH Policy on Clinical Trial Reporting

Quetiapine XR in Schizophrenic Patients

This study has been terminated.
(Planned number of 30 subjects could not be recruited during recruitment phase.)
Sponsor:
Collaborators:
Hannover Clinical Trial Center GmbH
AstraZeneca
Information provided by (Responsible Party):
Wolfgang Dillo, Hannover Medical School
ClinicalTrials.gov Identifier:
NCT01071135
First received: February 18, 2010
Last updated: November 10, 2011
Last verified: August 2011
No Study Results Posted on ClinicalTrials.gov for this Study
  Study Status: This study has been terminated.
  Study Completion Date: August 2010
  Primary Completion Date: August 2010 (Final data collection date for primary outcome measure)